R97 ICD 10 Code is a non-billable and non-specific code and should not be used to indicate a diagnosis for reimbursement purposes. There are other codes below it with greater level of diagnosis detail. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Codes
- R97.0 Elevated carcinoembryonic antigen [CEA]
- R97.1 Elevated cancer antigen 125 [CA 125]
- R97.2 Elevated prostate specific antigen [PSA]
- R97.20 Elevated prostate specific antigen [PSA]
- R97.21 Rising PSA following treatment for malignant neoplasm of prostate
- R97.8 Other abnormal tumor markers
Possible back-references that may be applicable or related to R97 ICD10 Code:
- R00-R99 Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- R97 Abnormal tumor markers
Present On Admission (POA Exempt)
R97 ICD 10 code is considered exempt from POA reporting